| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/1997 | CA2154979A1 Topical phenylephrine preparation |
| 01/28/1997 | US5597932 Intermediate for the preparation of 19-nor vitamin D compounds |
| 01/28/1997 | US5597928 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597927 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597922 Glycine receptor antagonist pharmacophore |
| 01/28/1997 | US5597920 Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes |
| 01/28/1997 | US5597919 Treatment of central nervous system disorders resulting from neurotransmitter dysfunction |
| 01/28/1997 | US5597915 Antagonists of cholecystokinin and gastrin receptors |
| 01/28/1997 | US5597849 Stick formulations for topical drug delivery of therapeutic agents and uses thereof |
| 01/28/1997 | US5597847 Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino) phenylacetic acid and process for their preparation |
| 01/28/1997 | US5597845 Tachykinin antagonists |
| 01/28/1997 | US5597844 Cimetidine granules coated with a partially hydrogenated vegetable oil |
| 01/28/1997 | US5597843 Beta-adrenergic receivers |
| 01/28/1997 | US5597842 3-heteroaryl-1-pyrrolidinealkanols and derivatives thereof and their therapeutic utility |
| 01/28/1997 | US5597839 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
| 01/28/1997 | US5597838 Reducing inflammation and cell proliferation, relieving memory dysfunction, inhibiting bacterial and fungal growth |
| 01/28/1997 | US5597837 Method and composition for treating psoriasis with styryl-substituted pyridyl compounds |
| 01/28/1997 | US5597833 Leukotriene synthesis inhibitors for antiinflammatory agents, respiratory system disorders, antiallergens or antiischemic agents |
| 01/28/1997 | US5597832 Tetracyclic compounds as dopamine agonists |
| 01/28/1997 | US5597830 Antitumor agents for prostate or breast cancer |
| 01/28/1997 | US5597829 Anticancer agent |
| 01/28/1997 | US5597828 Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds |
| 01/28/1997 | US5597827 Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597823 Treating benign prostatic hyperplasia |
| 01/28/1997 | US5597822 Pharmaceutical compositions for the prevention and/or treatment a gastrointestinal diseases |
| 01/28/1997 | US5597819 Antiinflammatory agents |
| 01/28/1997 | US5597818 Methods of treating cardiac arrhythmia |
| 01/28/1997 | US5597816 Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 01/28/1997 | US5597815 Prevention of hyperphosphatemia in kidney disorder patients |
| 01/28/1997 | US5597814 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 01/28/1997 | US5597813 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 01/28/1997 | US5597810 Administering nontoxic, nondigestible polymer |
| 01/28/1997 | US5597809 Methyl aspartate mediated retinal cell damage |
| 01/28/1997 | US5597808 Use of pseudopterosins for promoting wound healing |
| 01/28/1997 | US5597807 Immunological adjuvants |
| 01/28/1997 | US5597804 N-sulfonylarginine keto-amide compounds |
| 01/28/1997 | US5597797 Administering growth hormone and insulin-like growth factor |
| 01/28/1997 | US5597715 7,42-Bis(O-demethyl)rapamycin |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597583 Ibuprofen-cyclodextrin complex for oral administration in hot water |
| 01/28/1997 | US5597582 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 01/28/1997 | US5597578 TGF-β protein compositions for inhibition of cell proliferation |
| 01/28/1997 | US5597558 Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin |
| 01/28/1997 | US5597552 Dentinal desensitizing compositions |
| 01/28/1997 | CA2181422A1 Fenofibrate galenic formulations and uses thereof |
| 01/28/1997 | CA2068232C Pain controlling composition and method of preparation |
| 01/28/1997 | CA2061270C Method and composition for treating reperfusion injury |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/28/1997 | CA2012666C Diazepine antiallergy agents |
| 01/28/1997 | CA1338878C 14-beta-gal mammalian lectins |
| 01/27/1997 | CA2182113A1 N,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/27/1997 | CA2182112A1 N,n'-di(aralkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine and n-(aralkyl) n'-(carboxyalkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine derivatives and their use in pharmaceutical or cosmetic applications |
| 01/27/1997 | CA2181759A1 (thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| 01/23/1997 | WO1997002356A1 PRODUCTION OF β-GLUCAN-MANNAN PREPARATIONS BY AUTOLYSIS OF CELLS UNDER CERTAIN pH, TEMPERATURE AND TIME CONDITIONS |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1997002351A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | WO1997002347A1 A human map kinase homolog |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002285A1 Macrolides |
| 01/23/1997 | WO1997002284A1 New thrombin inhibitors, their preparation and use |
| 01/23/1997 | WO1997002279A1 Methods and compositions for modulation and inhibition of telomerase |
| 01/23/1997 | WO1997002269A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 01/23/1997 | WO1997002268A1 7,7-disubstituted cephem-4-ketones |
| 01/23/1997 | WO1997002267A1 New pyrido-thiopyranoindazoles with antitumor activity |
| 01/23/1997 | WO1997002266A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 01/23/1997 | WO1997002262A1 Fungicidal pyrimidinones |
| 01/23/1997 | WO1997002259A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002250A1 10-ACYLOXY-10,11-DIHYDRODIBENZ/b,f/AZEPINE-5-CARBOXAMIDES USEFUL FOR TREATING NERVOUS SYSTEM DISORDERS |
| 01/23/1997 | WO1997002249A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002242A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 01/23/1997 | WO1997002041A1 Transdermal and oral treatment of androgenic alopecia |
| 01/23/1997 | WO1997002039A1 Antibacterial synergistic composition comprising rifabutin |
| 01/23/1997 | WO1997002037A1 Compounds and pharmaceutical compositions containing them |
| 01/23/1997 | WO1997002036A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 01/23/1997 | WO1997002035A1 Method of retarding the progression of chronic renal failure |
| 01/23/1997 | WO1997002034A1 Anti-infection, anti-inflammatory and anti-tumour drug |
| 01/23/1997 | WO1997002033A1 Uricosuric agent |
| 01/23/1997 | WO1997002032A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/23/1997 | WO1997002031A1 Pharmaceutical amiodarone composition for parenteral delivery |
| 01/23/1997 | WO1997002030A1 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
| 01/23/1997 | WO1997002029A1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines |
| 01/23/1997 | WO1997002028A1 Inactivation of pathogens using hydroxymethylamines |
| 01/23/1997 | WO1997002027A1 Polyamine derivatives of 1-aminoindan |
| 01/23/1997 | WO1997002026A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 01/23/1997 | WO1997002025A1 Antibacterial/bactericidal/antiseptic agent, dermatologic preparation, and detergent composition |
| 01/23/1997 | WO1997002024A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | WO1997002023A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS |
| 01/23/1997 | WO1997002021A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 01/23/1997 | WO1997002020A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | WO1997002019A1 Polyester/carboxylic acid composite materials |
| 01/23/1997 | WO1997002017A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | WO1997002014A1 Therapeutic effervescent compositions |
| 01/23/1997 | WO1997002003A2 Compositions |
| 01/23/1997 | WO1996041634A3 Use of a non-nucleoside reverse transcriptase inhibitor in association with nucleoside inhibitors for the treatment of hiv infection |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |